A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia
Recruiting · NCT05865535 · Registry updated 2026-01-08Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia | Body Weight, Body Weight Changes, Cachexia, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Thinness, Weight Loss | Recruiting | Phase 1 | 2026-01-08 | NCT05865535 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AVEO Pharmaceuticals, Inc. | 4 |
12 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Advent Health Orlando Hospital | Orlando | United States | 1 |
| Astera Cancer Care | East Brunswick | United States | 38 |
| Beverly Hills Cancer Center | Beverly Hills | United States | 26 |
| Cancer and Blood Specialty Clinic | Lakewood | United States | 1 |
| Community Clinical Trials | Kingwood | United States | 6 |
| Hartford Hospital | Hartford | United States | 131 |
| Hoag Memorial Hospital | Newport Beach | United States | 18 |
| MUSC Hollings Cancer Center | Charleston | United States | 9 |
| Nebraska Cancer Specialists | Omaha | United States | 40 |
| New York Cancer and Blood Specialists | Shirley | United States | 14 |
| Oregon Health and Science University | Portland | United States | 382 |
| Vanderbilt University Henry-Joyce Cancer Clinic | Nashville | United States | 1 |